The foundation of innovation is rapidly changing in the life science sector and new technologies bring new challenges and opportunities for funding and support of early stage growth. This panel session will look at different models for supporting the translation/commercialization of early stage research and technology which are shaping the life science sector today.
Programme:
18:00 Registration over tea and coffee
18:30 Welcome from the hosts
18:40 Panel Q&A: The Evolution of Funding and Support for Early Stage Research
Chair: Fiona Nicolson, Partner, Bristows LLP
Panellists:
Dr Ian McKay, Innovation Lead for Advanced Therapies, Innovate UK
Donna Hackett, Head of Commercial Translation, The Francis Crick Institute
Dr Derek Sheader, Business Development Manager, LifeArc
Dr Daniel Marshall, Senior Associate, Epidarex Capital
19.30 Networking over drinks and canapes
21:00 Close
Prices
Members: Free
Non-members: £50 +VAT
Academics: please contact alicia@onenucleus.com
**This button will not work if you are not logged in**
BioWednesday London: The Evolution of Funding and Support for Early Stage Research
100 Victoria Embankment
London EC4Y 0DH
United Kingdom